Nitric oxide sensitizes ovarian tumor cells to Fas-induced apoptosis. Gynecol Oncol ; 73 — Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K murine melanoma cells. J Exp Med ; — Suppression of tumorigenicity and metastasis of human renal carcinoma cells by infection with retroviral vectors harboring the murine inducible nitric oxide synthase gene.
Nitric oxide synthase activity in human gynecological cancer. Cancer Res ; 54 —4. Nitric oxide synthase activity in human breast cancer. Br J Cancer ; 72 —4. Nathan C. Inducible nitric oxide synthase: what difference does it make? J Clin Invest. Gastroenterology ; — Nitric oxide synthase in human breast cancer is associated with tumor grade, proliferation rate, and expression of progesterone receptors.
Lab Invest ; 79 — Inducible nitric oxide synthase expression, apoptosis, and angiogenesis in in situ and invasive breast carcinomas. Clin Cancer Res ; 6 — Expression of endothelial and inducible nitric oxide synthase in benign and malignant lesions of the breast and measurement of nitric oxide using electron paramagnetic resonance spectroscopy.
Cancer ; 95 —8. Nitric Oxide ; 6 Google Scholar. Int J Oncol ; 17 — Endothelial nitric oxide synthase: correlation with histologic grade, lymph node status and estrogen receptor expression in human breast cancer.
Tumour Biol ; 21 —7. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositolOH kinase, Nature ; — Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. Circ Res ; 87 — Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation.
Nature ; —5. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature ; — Dynamic activation of endothelial nitric oxide synthase by Hsp Nature ; —4. Relationships between caveolae and eNOS: everything in proximity and the proximity of everything. Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression.
Cancer Res ; 58 — Aberrant expression of nitric oxide synthase in human polyps, neoplastic colonic mucosa and surrounding peritumoral normal mucosa. Carcinogenesis ; 15 —5. Expression of nitric oxide synthase in human central nervous system tumors.
Cancer Res ; 55 — Immunohistochemical characterization of nitric oxide synthase activity in squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg ; —9. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas.
Vascular endothelial growth factor and nitric oxide synthase expression in human lung cancer and the relation to p Br J Cancer ; 78 —9. Selective expression of inducible nitric oxide synthase in human prostate carcinoma.
Cancer ; 82 — Inducible nitric oxide synthase with transitional cell carcinoma of the bladder. J Urol ; —4. Role of nitric oxide in pancreatic tumour growth: in vivo and in vitro studies.
Nitric oxide synthases in Kaposi' sarcoma are expressed predominantly by vessels and tissue macrophages. Lab Invest ; 78 : — Roles of nitric oxide in tumor growth. Nat Med ; 4 —6. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science ; —3. Nitric oxide induced p53 accumulation and regulation of inducible nitric oxide synthase NOS2 expression by wild type p Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression.
Up-regulation of inducible nitric oxide synthase expression in cancer-prone p53 knockout mice. Nitric oxide activation of poly ADP-ribose synthetase in neurotoxicity. Science ; —9. Shibuya, N. A novel pathway for the production of hydrogen sulfide from d-cysteine in mammalian cells. Asimakopoulou, A.
Hydrogen sulfide is an endogenous stimulator of angiogenesis. Coletta, C. Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation. This study shows evidence for cooperative signalling between NO and H 2 S in the control of angiogenesis and vascular relaxation.
Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part I. Biochemical and physiological mechanisms. Bhattacharyya, S. Cystathionine beta-synthase CBS contributes to advanced ovarian cancer progression and drug resistance.
Guo, H. Urology 79 , Sen, S. Chao, C. Nitric Oxide 39 , S21—S22 Takano, N. Hellmich, M. Panza, E. Pigment Cell Melanoma Res. De Vos, J. Comparison of gene expression profiling between malignant and normal plasma cells with oligonucleotide arrays. Oncogene 21 , — Hansel, D. Identification of novel cellular targets in biliary tract cancers using global gene expression technology.
Zhang, W. Expression profiling of homocysteine junction enzymes in the NCI60 panel of human cancer cell lines. Jurkowska, H. Szczesny, B. Hydrogen sulfide in lung adenocarcinoma: a tumor cell survival factor, an enhancer of mitochondrial DNA repair and a cellular bioenergetic stimulator. Nitric Oxide 47 , S46 Fan, K. Cell Signal. Zatarain, J. Gastroenterology , S Perry, T. Failure of aminooxyacetic acid therapy in Huntington disease. Neurology 30 , — Guth, P. Evaluation of amino-oxyacetic acid as a palliative in tinnitus.
Li, L. Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule GYY : new insights into the biology of hydrogen sulfide. Circulation , — Han, Y. Lee, Z. Utilizing hydrogen sulfide as a novel anti-cancer agent by targeting cancer glycolysis and pH imbalance.
The slow-releasing hydrogen sulfide donor, GYY, exhibits novel anti-cancer effects in vitro and in vivo. This study demonstrates the inhibitory effects of a slow-releasing H 2 S donor on tumour growth in vivo. Lu, S. Benavides, G. Hydrogen sulfide mediates the vasoactivity of garlic. Insko, M. Detection of exhaled hydrogen sulphide gas in rats exposed to intravenous sodium sulphide. Predmore, B. The polysulfide diallyl trisulfide protects the ischemic myocardium by preservation of endogenous hydrogen sulfide and increasing nitric oxide bioavailability.
Heart Circ. Yi, L. Molecular mechanisms for the anti-cancer effects of diallyl disulfide. Food Chem. Singh, S. Garlic constituent diallyl trisulfide prevents development of poorly differentiated prostate cancer and pulmonary metastasis multiplicity in TRAMP mice. Wu, P. Phytomedicine 18 , — Li, W. Diallyl trisulfide induces apoptosis and inhibits proliferation of A cells in vitro and in vivo.
Acta Biochim. Shanghai 44 , — Wallace, G. Ma, K. Chattopadhyay, M. Kashfi, K. Biology and therapeutic potential of hydrogen sulfide and hydrogen sulfide-releasing chimeras. Gemici, B. H2S-releasing drugs: anti-inflammatory, cytoprotective and chemopreventative potential.
Nitric Oxide 46 , 25—31 Gaseotransmitters: new frontiers for translational science. NOSH-aspirin NBS , a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell growth in vitro and in a xenograft mouse model.
Maksimovic-Ivanic, D. Anticancer properties of the novel nitric oxide-donating compound S,R phenyl-4,5-dihydroisoxazole acetic acid—nitric oxide in vitro and in vivo. Mijatovic, S. Induction of caspase-independent apoptotic-like cell death of mouse mammary tumor TA3Ha cells in vitro and reduction of their lethality in vivo by the novel chemotherapeutic agent GITNO. Donia, M. In vitro and in vivo anticancer action of Saquinavir-NO, a novel nitric oxide-derivative of the protease inhibitor saquinavir, on hormone resistant prostate cancer cells.
Cell Cycle 10 , — Unique antineoplastic profile of Saquinavir-NO, a novel NO-derivative of the protease inhibitor Saquinavir, on the in vitro and in vivo tumor formation of A human melanoma cells.
Elsheikh, W. Enhanced chemopreventive effects of a hydrogen sulfide-releasing anti-inflammatory drug ATB in experimental colorectal cancer. Nitric Oxide 41 , — Moriyama, A. Chan, H. Exhaled breath analysis: novel approach for early detection of lung cancer. Lung Cancer 63 , — This paper presents an approach of measuring patient-exhaled levels of NO for the detection of lung cancer.
Yin, H. Upregulation of heme oxygenase-1 in colorectal cancer patients with increased circulation carbon monoxide levels, potentially affects chemotherapeutic sensitivity.
BMC Cancer 14 , This study indicates there are increased levels of the CO metabolite carboxyhaemoglobin in the circulation of patients with cancer. Bonavida, B.
Nitric Oxide 24 , 1—7 Bhowmick, R. Cytoprotective signaling associated with nitric oxide upregulation in tumor cells subjected to photodynamic therapy-like oxidative stress.
Furfaro, A. HO-1 up-regulation: a key point in high-risk neuroblastoma resistance to bortezomib. Sanokawa-Akakura, R. A H2S-Nampt dependent energetic circuit is critical to survival and cytoprotection from damage in cancer cells. Ostrakhovitch, E. Dedifferentiation of cancer cells following recovery from a potentially lethal damage is mediated by H2S-Nampt.
Cell Res. Eyler, C. Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase Cell , 53—66 Herrmann, H. Cancer Drug Targets 12 , 51—63 Kim, R. Fractionated radiation-induced nitric oxide promotes expansion of glioma stem-like cells. Cancer Sci. Rao, C. Nitric oxide signaling in colon cancer chemoprevention. Therapeutic potential of nitric oxide in cancer.
Drug Resist. Burke, A. The yin and yang of nitric oxide in cancer progression. Carcinogenesis 34 , — Grochot-Przeczek, A. Haem oxygenase non-canonical roles in physiology and pathology.
Carbonero, F. Contributions of the microbial hydrogen economy to colonic homeostasis. Kilbourn, R. Beneficial versus detrimental effects of nitric oxide synthase inhibitors in circulatory shock: lessons learned from experimental and clinical studies. Shock 7 , — Kondapaneni, M. Inducible nitric oxide synthase iNOS is not required for ILinduced hypotension and vascular leak syndrome in mice. Samlowski, W. Endothelial nitric oxide synthase is a key mediator of interleukininduced hypotension and vascular leak syndrome.
Maybauer, D. Lung-protective effects of the metalloporphyrinic peroxynitrite decomposition catalyst WW in interleukin-2 induced toxicity. Strategies to reduce side effects of interleukin evaluation of the antihypotensive agent N G -monomethyl- L -arginine. Cancer J. Ashburn, T. Drug repositioning: identifying and developing new uses for existing drugs.
Blatt, J. Drug repurposing in pediatrics and pediatric hematology oncology. Mitochondrial diseases in north america. Betts, J. Molecular neuropathology of melas: level of heteroplasmy in individual neurones and evidence of extensive vascular involvement. Bishop, D. High-intensity exercise and mitochondrial biogenesis: current controversies and future research directions. Physiology 34, 56— Bon, C. Bruckdorfer, R. The basics about nitric oxide. Curis, E. Almost all about citrulline in mammals.
Amino Acids Desquiret-Dumas, V. Metabolically induced heteroplasmy shifting and l-arginine treatment reduce the energetic defect in a neuronal-like model of melas. Acta , — Dioguardi, F. To Give or Not to Give? Lessons from the Arginine Paradox.
Nutrigenomics 4, 90— Dyakova, E. Physical exercise associated with no production: signaling pathways and significance in health and disease.
Cell Dev. El-Hattab, A. Impaired nitric oxide production in children with melas syndrome and the effect of arginine and citrulline supplementation. Restoration of impaired nitric oxide production in melas syndrome with citrulline and arginine supplementation. Nitric oxide synthases: regulation and function. Heart J. Furchgott, R. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature , — Ganetzky, R. Gewaltig, M. Vasoprotection by nitric oxide: mechanisms and therapeutic potential.
Gorman, G. Mitochondrial Diseases. Ignarro, L. Ikawa, M. Care 23, 17— Keshet, R. Model Mech. Kitamura, M. Koenig, M. JAMA Neurol. Koga, Y. Neurology 66, — Neurology 64, — Neurology 58, — The volume reviews significant advances in the biochemical and molecular biology of NO-mediated effects in cancer. Additionally, it explores NO and its relationship to cancer, delineating its roles in the pathogenesis, prognosis, gene and protein modifications, regulation of resistance to cytotoxic drugs and immunotherapies, and potential therapeutic applications.
Nitric Oxide and Cancer addresses the burgeoning interest in a rapidly advancing field, and serves as both a valuable resource for scientists, clinicians, students, and health professionals and a reference for teaching and educational purposes.
It can be recommended to all readers who are interested in the pathogenesis and therapy of cancer. Skip to main content Skip to table of contents. Advertisement Hide. This service is more advanced with JavaScript available. Nitric Oxide and Cancer: Pathogenesis and Therapy. Editors view affiliations Benjamin Bonavida.
0コメント